Pancreatic Cancer Trial, Recruiting NCT07241663 Sponsor: Azienda Ospedaliera di Padova Condition: Pancreatic Cancer
Back to Pancreatic Cancer

Pancreatic Cancer Trial, Recruiting

NCT07241663
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are older than 18 years of age
  • People who are able to give their informed consent to participate
  • People whose cancer has been confirmed by laboratory testing to be pancreatic adenocarcinoma (a specific type of pancreatic cancer)
  • People whose pancreatic cancer was classified as locally advanced at the time of diagnosis, according to a specific staging system called NCCN
  • People who have already received at least 4 months of chemotherapy treatment before joining the trial
  • People whose cancer showed either stable disease or a partial response (meaning the cancer did not grow, or it shrank somewhat) after that initial chemotherapy, as measured by standard imaging assessment guidelines
  • People who a local specialist medical team has assessed as suitable candidates for surgery aimed at fully removing the cancer

Who may not be able to join:

  • People who withdraw or take back their consent to participate
  • People whose tumour has characteristics that would make surgery not possible
  • People who have other significant health conditions that would make surgery not safe or possible
  • People for whom abdominal scan images taken before the initial chemotherapy are not available
  • People whose cancer testing confirms a tumour type other than pancreatic adenocarcinoma

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Azienda Ospedaliera di Padova
Registry
ClinicalTrials.gov
Start date
1 January 2025
Est. completion
31 December 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

HRQoL deterioration-free survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov